SCHEMBL1289421

SCHEMBL1289421

C[Si](C)(C)CCOCCOCCOCC[Si](C)(C)C

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL419805 1.00 MEN1 (0.32) MEN1KMT2A
SCHEMBL430949 0.96
SCHEMBL30621784 0.88 CA2 (0.34)
SCHEMBL1041150 0.88 CA2 (0.34)
SCHEMBL10158608 0.84 HSD17B10 (0.35)
SCHEMBL7698403 0.82
SCHEMBL2992565 0.82
SCHEMBL17585473 0.82
SCHEMBL2355451 0.82 TSHR (0.56) MEN1KMT2A
SCHEMBL14899281 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4013795-A1 TREATMENT OF CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS Agensys, Inc. (US) 2022-06-22 EP disclosed
EP-3890778-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-191P4D12 ANTIBODY DRUG CONJUGATES AND METHODS OF USE THEREOF Agensys, Inc. (US) 2021-10-13 EP disclosed
WO-2020117373-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-191P4D12 ANTIBODY DRUG CONJUGATES AND METHODS OF USE THEREOF AGENSYS, INC. (US) 2020-06-11 WO disclosed
EP-3268353-A1 PYRAZOLYL-DERIVATIVES AS PEST CONTROL AGENTS Bayer Animal Health GmbH (DE) 2018-01-17 EP disclosed
EP-3157913-A1 PYRAZOLYL-TRIAZOLYL-PYRIDINES AS PEST-CONTROL AGENTS Bayer Animal Health GmbH (DE) 2017-04-26 EP disclosed
EP-3089972-A1 NOVEL PYRAZOLYL-HETEROARYLAMIDES AS PESTICIDES Bayer Animal Health GmbH (DE) 2016-11-09 EP disclosed
WO-2016142394-A1 PYRAZOLYL-DERIVATIVES AS PEST CONTROL AGENTS BAYER ANIMAL HEALTH GMBH (DE) 2016-09-15 WO disclosed
EP-3027220-A1 ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO CD37 PROTEINS Agensys, Inc. (US) 2016-06-08 EP disclosed
EP-2964632-A1 NOVEL HALOGEN-SUBSTITUTED COMPOUNDS Bayer CropScience Aktiengesellschaft (DE) 2016-01-13 EP disclosed
EP-2964631-A1 NOVEL HALOGEN-SUBSTITUTED COMPOUNDS Bayer Animal Health GmbH (DE) 2016-01-13 EP disclosed
EP-2054427-A2 AVERMECTIN DERIVATIVES Bayer CropScience AG (DE) 2009-05-06 EP disclosed
WO-2009052431-A2 CD19 BINDING AGENTS AND USES THEREOF SEATTLE GENETICS, INC. (US) 2009-04-23 WO disclosed
WO-2009048967-A1 COMBINATION THERAPY WITH ANTIBODY-DRUG CONJUGATES SEATTLE GENETICS, INC. (US) 2009-04-16 WO disclosed
WO-2008153278-A1 PHOSPHAZENE HYDROGELS WITH CHEMICAL CORSS -LINK, PREPARATION METHOD THEREOF AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2008-12-18 WO disclosed
WO-2008153277-A1 POLY(ORGANOPHOSPHAZENE) HYDROGELS FOR DRUG DELIVERY, PREPARATION METHOD THEREOF AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2008-12-18 WO disclosed
EP-2001513-A1 THERMOSENSITIVE POLYPHOSPHAZENE-BIOACTIVE MOLECULE CONJUGATES, PREPARATION METHOD THEROF AND USE THEREOF Korea Institute of Science and Technology (KR) 2008-12-17 EP disclosed
WO-2008019784-A2 AVERMECTIN DERIVATIVES BAYER CROPSCIENCE AG (DE) 2008-02-21 WO disclosed
WO-2007114549-A1 THERMOSENSITIVE POLYPHOSPHAZENE-BIOACTIVE MOLECULE CONJUGATES, PREPARATION METHOD THEROF AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2007-10-11 WO disclosed
EP-1412346-A1 METHOD FOR PRODUCING NOVEL SPINOSYN DERIVATIVES Bayer CropScience AG (DE) 2004-04-28 EP disclosed
WO-2003010155-A1 METHOD FOR PRODUCING NOVEL SPINOSYN DERIVATIVES BAYER CROPSCIENCE AG (DE) 2003-02-06 WO disclosed